RecruitingNot ApplicableNCT06438445

Effects of Royal Jelly Supplementation in Chronic Kidney Disease

Effects of Royal Jelly Supplementation on Inflammation and Cellular Senescence in Chronic Kidney Disease Patients Under Hemodialysis


Sponsor

Universidade Federal Fluminense

Enrollment

30 participants

Start Date

Jul 30, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The objective of this study is to evaluate the effects of royal jelly on inflammation and cellular senescence in patients with chronic kidney disease (CKD) on hemodialysis (HD).


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether royal jelly — a natural substance produced by honeybees — can improve health outcomes (such as inflammation, nutrition, and blood vessel health) in patients with chronic kidney disease who are on hemodialysis (regular dialysis to filter blood). **You may be eligible if...** - You have chronic kidney disease and have been receiving hemodialysis for at least 6 months - You have an arteriovenous fistula (a surgically created connection between an artery and vein) as your dialysis access site **You may NOT be eligible if...** - You are pregnant or breastfeeding - You are a smoker - You have taken antibiotics or antioxidant supplements in the past 3 months - You have autoimmune or active infectious diseases - You have cancer, liver disease, or AIDS Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTReal Jelly

Participants will receive 500mg of royal jelly capsules per day for two months.

DIETARY_SUPPLEMENTPlacebo

Participants will receive 500mg of placebo capsules per day for two months.


Locations(1)

Denise Mafra

Rio de Janeiro, Rio de Janeiro, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06438445


Related Trials